首页 | 本学科首页   官方微博 | 高级检索  
     


Dose conversion factor between cyclosporine and tacrolimus in pediatric heart transplant recipients
Affiliation:1. School of Medicine, Seattle Children’s Hospital, University of Washington, Seattle, Washington;2. Department of Biostatistics, Seattle Children’s Hospital, University of Washington, Seattle, Washington;3. Division of Pediatric Cardiology, Seattle Children’s Hospital, University of Washington, Seattle, Washington;1. Infectious Diseases Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain;2. Therapeutic Drug Monitoring Unit, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain;3. Hematology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain;4. Pulmonology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain;1. Heart and Vascular Institute, Advocate Christ Medical Center, Oak Lawn, Illinois;2. Department of Surgery, Division of Cardiac Surgery, Northwestern University, Chicago, Ilinois;3. Cardiovascular Surgery Research, University of Alabama at Birmingham, Alabama;4. Department of Medicine, Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio;5. Department of Cardiothoracic Surgery, University of Alabama, Birmingham, Alabama;1. University Paris-Sud, National Reference Center for Severe Pulmonary Hypertension, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France;2. Department of Medicine, University of California at San Diego, La Jolla, California;3. Institute of Cardiology, Bologna University Hospital, Bologna, Italy;4. Division of Pediatric Cardiology, Columbia University, New York, New York;5. Department of Biostatistics, University of Washington, Seattle, Washington;6. Department of Medicine, Section of Pulmonary and Critical Care, Baylor College of Medicine, Houston, Texas;7. Pulmonary Hypertension Program, The Christ Hospital, Cincinnati, Ohio;8. Pulmonary Institute, Rabin Medical Center, Petah Tikva, Israel;9. Pfizer Inc, New York, New York;10. Worldwide Pharmaceutical Operations, Pfizer Ltd, Sandwich, Kent, United Kingdom;11. Division of Pulmonary Sciences and Critical Care Medicine, and Cardiology Director, Pulmonary Hypertension Program, University of Colorado Denver, Denver, Colorado;1. Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil;2. Fundação Pró-Sangue/Hemocentro of São Paulo, Molecular Biology Department, São Paulo, Brazil;3. Infectious Disease Division (DIPA), Federal University of São Paulo, São Paulo, Brazil;1. Department of Cardiothoracic Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;2. Department of Cardiology, Division of Lung Transplantation, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;3. Department of Diagnostic Radiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;4. Department of Surgical Gastroenterology, Division of Liver Transplantation, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;5. Department of Cardiothoracic Surgery, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;1. Division of Cardiothoracic Transplantation, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania;2. Division of Pulmonary Allergy and Critical Medicine, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号